Skip to main content
Code
UCDC

6th International Symposium on Urea Cycle Disorders, September 1-2, 2025

6th International Symposium on Urea Cycle Disorders

Advancements in Understanding: Global Perspectives and Innovations in Urea Cycle Disorders

September 1-2, 2025

Understanding Seizures and Epilepsy in Urea Cycle Disorders

Learn how this study explored the connection between ammonia buildup in the brain and the development of seizures and epilepsy.

Liver Transplantation and Health Outcomes in Urea Cycle Disorders

This research looked at how liver transplantation affects health outcomes in people with UCDs.

Health Risks for Females with Ornithine Transcarbamylase Deficiency (OTCD)

UCDC researched factors that could predict complications in women with OTCD by reviewing data from 302 females in the Urea Cycle Disorders Consortium (UCDC) and performing brain scans on one patient.

Impact of L-Citrulline/Arginine Supplementation After Liver Transplantation in Urea Cycle Disorders

UCDC researched how L-citrulline/arginine supplementation affects individuals with urea cycle disorders (UCDs) after liver transplantation.

Quality of Life Challenges in Urea Cycle Disorders

UCDC recently conducted a study focusing on how urea cycle disorders (UCDs) affect the quality of life.

Using Phenylbutyrate Metabolite Testing to Monitor Treatment for Urea Cycle Disorders

UCDC recently conducted a study to look at how testing phenylbutyrate metabolites can help treat people with urea cycle disorders (UCDs).

Watch: Susan Berry, MD, Describes Longitudinal Study of Urea Cycle Disorders

The Urea Cycle Disorders Consortium (UCDC) is conducting a longitudinal investigation of the natural history, morbidity, and mortality in people with urea cycle disorders (UCD). In this video, UCDC Principal Investigator